GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (NAS:OCS) » Definitions » Inventories, Other

Oculis Holding AG (Oculis Holding AG) Inventories, Other : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Oculis Holding AG's other inventories for the quarter that ended in Mar. 2024 was $0.00 Mil.


Oculis Holding AG Inventories, Other Historical Data

The historical data trend for Oculis Holding AG's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Inventories, Other Chart

Oculis Holding AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Inventories, Other
- - - -

Oculis Holding AG Quarterly Data
Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oculis Holding AG Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Oculis Holding AG (Oculis Holding AG) Business Description

Traded in Other Exchanges
Address
Bahnhofstrasse 7, Zug, CHE, 6300
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.